Lista de obras - José Moltó - Dominio Público Uruguay

A survey of trichothecenes, zearalenone and patulin in milled grain-based products using GC–MS/MS ⬇️

artículo científico publicado el 19 de septiembre de 2013

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.

artículo científico publicado en 2009

Aging in HIV-Infected Subjects: A New Scenario and a New View

artículo científico publicado en 2017

Atazanavir exposure is effective during pregnancy regardless of tenofovir use.

artículo científico publicado en 2014

Binding neutral information to emotional contexts: Brain dynamics of long-term recognition memory.

artículo científico publicado en 2015

Clinical Pharmacology of the Synthetic Cathinone Mephedrone

artículo científico publicado en 2016

Clinical utility of maraviroc.

scientific article published on January 2011

Co-infection of Mycobacterium tuberculosis and Mycobacterium leprae in human archaeological samples: a possible explanation for the historical decline of leprosy

artículo científico publicado en 2005

Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients.

artículo científico publicado en 2008

Decomposition of two types of electric wires considering the effect of the metal in the production of pollutants.

artículo científico publicado en 2012

Deficient aversive-potentiated startle and the triarchic model of psychopathy: The role of boldness.

artículo científico publicado en 2016

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

artículo científico publicado en 2013

Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

artículo científico publicado en 2011

Effect of lithium on HIV-1 expression and proviral reservoir size in the CD4+ T cells of antiretroviral therapy suppressed patients

artículo científico publicado en 2014

Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients.

artículo científico publicado en 2012

Effects of salvage logging on soil properties and vegetation recovery in a fire-affected Mediterranean forest: A two year monitoring research

artículo científico publicado en 2017

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Emotional reactivity during anticipation and perception of affective pictures

artículo científico publicado en 2014

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women

artículo científico publicado en 2016

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins

FFM description of the triarchic conceptualization of psychopathy in men and women

artículo científico publicado en 2013

Factors associated with resistance to human immunodeficiency virus protease inhibitors

artículo científico publicado en 2002

Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy

artículo científico publicado en 2000

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain

artículo científico publicado en 2009

Herb-drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV-infected patients.

artículo científico publicado en 2010

Influence of Prior Structured Treatment Interruptions on the Length of Time without Antiretroviral Treatment in Chronically HIV-Infected Subjects

article

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

artículo científico publicado en 2010

Levels of dioxin-like PCBs in low-volume serum samples of male patients attending fertility clinics.

artículo científico publicado en 2015

Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence

artículo científico publicado en 2005

Lopinavir/ritonavir monotherapy as a simplification strategy in routine clinical practice

scientific article published on 07 June 2007

Lopinavir/ritonavir pharmacokinetics in HIV and hepatitis C virus co-infected patients without liver function impairment: influence of liver fibrosis.

artículo científico publicado en 2007

Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study).

artículo científico publicado en 2005

Low temperature thermal degradation of PCDD/Fs in soil using nanosized particles of zerovalent iron and CaO.

artículo científico publicado en 2013

Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients

artículo científico publicado en 2005

Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice.

artículo científico publicado en 2007

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

article

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients

artículo científico publicado en 2008

P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load

artículo científico publicado en 2016

Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women.

artículo científico publicado en 2014

Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients.

artículo científico publicado en 2016

Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.

artículo científico publicado en 2008

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

scientific article published on 01 January 2014

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C).

artículo científico publicado en 2013

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

artículo científico publicado en 2014

Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease

artículo científico publicado en 2016

Resistance to protease inhibitors in HIV patients experiencing virologic failure despite adherence to antiretroviral therapy.

artículo científico publicado en 2001

Ritonavir boosting dose reduction from 100 to 50 mg does not change the atazanavir steady-state exposure in healthy volunteers.

artículo científico publicado en 2012

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis

artículo científico publicado en 2009

Saquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy in long-term virologically suppressed HIV-infected patients

artículo científico publicado en 2010

Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial

artículo científico publicado en 2016

Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients

artículo científico publicado en 2013

Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.

artículo científico publicado en 2008

Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers

artículo científico publicado en 2015

Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.

artículo científico publicado en 2008

Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL

article

The pharmacokinetics of abacavir 600 mg once daily in HIV-1-positive pregnant women.

artículo científico publicado en 2016

The pharmacokinetics, safety and efficacy of boosted saquinavir tablets in HIV type-1-infected pregnant women.

artículo científico publicado en 2009

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women ⬇️

artículo científico publicado el 13 de marzo de 2013

Therapeutic drug monitoring of antiretroviral agents scenario.

artículo científico publicado en 2004

Thermal decomposition of electronic wastes: mobile phone case and other parts.

artículo científico publicado en 2011

Thermogravimetric kinetic analysis and pollutant evolution during the pyrolysis and combustion of mobile phone case ⬇️

artículo científico publicado el 8 de septiembre de 2011

Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study

artículo científico publicado en 2017

Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in heavily pretreated HIV-infected patients.

artículo científico publicado en 2010

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

artículo científico publicado en 2004

Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.

artículo científico publicado en 2016

Use of herbal remedies among HIV-infected patients: patterns and correlates

artículo científico publicado en 2011

Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice.

artículo científico publicado en 2006

Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice

artículo científico publicado en 2007

Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.

artículo científico publicado en 2013

Lista de obras de José Moltó

A survey of trichothecenes, zearalenone and patulin in milled grain-based products using GC–MS/MS ⬇️

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.

Aging in HIV-Infected Subjects: A New Scenario and a New View

Atazanavir exposure is effective during pregnancy regardless of tenofovir use.

Binding neutral information to emotional contexts: Brain dynamics of long-term recognition memory.

Clinical Pharmacology of the Synthetic Cathinone Mephedrone

Clinical utility of maraviroc.

Co-infection of Mycobacterium tuberculosis and Mycobacterium leprae in human archaeological samples: a possible explanation for the historical decline of leprosy

Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients.

Decomposition of two types of electric wires considering the effect of the metal in the production of pollutants.

Deficient aversive-potentiated startle and the triarchic model of psychopathy: The role of boldness.

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

Effect of lithium on HIV-1 expression and proviral reservoir size in the CD4+ T cells of antiretroviral therapy suppressed patients

Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients.

Effects of salvage logging on soil properties and vegetation recovery in a fire-affected Mediterranean forest: A two year monitoring research

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Emotional reactivity during anticipation and perception of affective pictures

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins

FFM description of the triarchic conceptualization of psychopathy in men and women

Factors associated with resistance to human immunodeficiency virus protease inhibitors

Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain

Herb-drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV-infected patients.

Influence of Prior Structured Treatment Interruptions on the Length of Time without Antiretroviral Treatment in Chronically HIV-Infected Subjects

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

Levels of dioxin-like PCBs in low-volume serum samples of male patients attending fertility clinics.

Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence

Lopinavir/ritonavir monotherapy as a simplification strategy in routine clinical practice

Lopinavir/ritonavir pharmacokinetics in HIV and hepatitis C virus co-infected patients without liver function impairment: influence of liver fibrosis.

Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study).

Low temperature thermal degradation of PCDD/Fs in soil using nanosized particles of zerovalent iron and CaO.

Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients

Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice.

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients

P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load

Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women.

Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients.

Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C).

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease

Resistance to protease inhibitors in HIV patients experiencing virologic failure despite adherence to antiretroviral therapy.

Ritonavir boosting dose reduction from 100 to 50 mg does not change the atazanavir steady-state exposure in healthy volunteers.

Saquinavir exposure in HIV-infected patients with chronic viral hepatitis

Saquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy in long-term virologically suppressed HIV-infected patients

Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial

Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients

Simultaneous population pharmacokinetic model for lopinavir and ritonavir in HIV-infected adults.

Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers

Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.

Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL

The pharmacokinetics of abacavir 600 mg once daily in HIV-1-positive pregnant women.

The pharmacokinetics, safety and efficacy of boosted saquinavir tablets in HIV type-1-infected pregnant women.

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women ⬇️

Therapeutic drug monitoring of antiretroviral agents scenario.

Thermal decomposition of electronic wastes: mobile phone case and other parts.

Thermogravimetric kinetic analysis and pollutant evolution during the pyrolysis and combustion of mobile phone case ⬇️

Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study

Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in heavily pretreated HIV-infected patients.

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.

Use of herbal remedies among HIV-infected patients: patterns and correlates

Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice.

Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice

Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.